Applied Stemcell, Inc.

Milpitas, CA

UEI
SSENYXM7HCF1
CAGE
5NEY8
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
521 Cottonwood Dr #111, Milpitas, CA 95035, USA
Founded
2008
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Industrials
  2. Commercial & Professional Services
  3. Professional Services

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 -$10,000
FY2025 -$18,800
FY2024 -$2,607

Contract awards

Award Agency Obligated Awarded
Mice containing the daglb-tdtomato knock-in model for live animal imaging 75N95022P00692 National Institute on Drug Abuse (NIH) $29,565
GABBR1-flox mouse model - research animal-direct use 75N95D22P00116 National Institute on Aging (NIH) $12,600
Transgenic mouse generation service 36C26122P1694 Veterans Integrated Service Network 21 (VHA) $20,000
Prion cell cloning and genotyping services 75N93022P00830 National Institute of Allergy and Infectious Diseases (NIH) $32,100
This firm fixed price purchase order is awarded for a large fragment knock-in mouse and related services to applied… 75N94022P00445 National Institute of Child Health and Human Development (NIH) $22,000

Latest 5 listed here. See the rest on GovTribe.

Grant awards

Award Agency Obligated Awarded
Targeted gene insertion by directed evolution of ????C31 integrase for therapeutic gene editing R44GM136045 National Institute of General Medical Sciences (NIH) $3,243,323
Improving CAS9 mediated homologous recombination in pluripotent stem cells R41GM115028 National Institutes of Health $224,518
Modernize animal pharming with emerging gene targeting technologies R41GM110822 National Institutes of Health $186,180
Development of CRE driver RAT strains for creating conditional and physiologically relevant models of human diseases R44GM108071 National Institute of General Medical Sciences (NIH) $1,282,596
Development of novel RAT models for site-specific transgene integration R43GM108071 National Institutes of Health $217,900

Similar vendors

Vendor Location Primary NAICS
Synthego Corporation UEI RNDBNJAKTJC9 — 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Feldan Bio Inc. UEI MRCELQRLYHR3 Québec, QC —
Revvity Discovery LIMITED UEI GVL1VW27D7F4 England 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Editco Bio Inc. UEI MN9PSNE16SJ8 Redwood City, CA 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Recombinetics Inc. UEI L99NWZNZ7K57 — 541714 Research and Development in Biotechnology (except Nanobiotechnology)

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Applied Stemcell, Inc. - doing business as Applied Stemcell Inc. - is a biotechnology company that provides gene editing services and GMP iPSC manufacturing to support cell-based research projects. They offer services spanning from preclinical efficacy testing to cGMP compliant cell production.

Through past federal contract awards, Applied Stemcell has provided gene editing services to generate customized cell and animal models, including knockout mouse models, reporter cell lines, and stem cell models with disease-associated mutations. These services have been provided to agencies such as NIH, NIAID, NIDDK, NICHD, and NIA through purchase orders and contracts. While most awards were not set aside, Applied Stemcell is registered as a minority owned, woman owned small business.

Through a past federal grant from NIGMS, Applied Stemcell performed research to develop improved gene editing technology by directed evolution of φC31 integrase for therapeutic gene editing applications.

Quick answers

Is Applied Stemcell, Inc. registered in SAM.gov?

Yes. Applied Stemcell, Inc.'s SAM.gov registration is active through March 12, 2027.

What is Applied Stemcell, Inc.'s CAGE code?

Applied Stemcell, Inc.'s CAGE code is 5NEY8, and its Unique Entity ID (UEI) is SSENYXM7HCF1.

What is Applied Stemcell, Inc.'s most recent federal award?

Applied Stemcell, Inc.'s most recent federal contract award is Mice containing the daglb-tdtomato knock-in model for live animal imaging (75N95022P00692), from National Institute on Drug Abuse (NIH), on September 20, 2022.

On GovTribe

See Applied Stemcell, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login

Find teaming partners on GovTribe